Skip to main content
Erschienen in: Journal of Genetic Counseling 5/2018

23.02.2018 | Original Research

Pregnant Women’s Perspectives on Expanded Carrier Screening

verfasst von: Lauren Propst, Gwendolyn Connor, Megan Hinton, Tabitha Poorvu, Jeffrey Dungan

Erschienen in: Journal of Genetic Counseling | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Expanded carrier screening (ECS) is a relatively new carrier screening option that assesses many conditions simultaneously, as opposed to traditional ethnicity-based carrier screening for a limited number of conditions. This study aimed to explore pregnant women’s perspectives on ECS, including reasons for electing or declining and anxiety associated with this decision-making. A total of 80 pregnant women were surveyed from Northwestern Medicine’s Clinical Genetics Division after presenting for aneuploidy screening. Of the 80 participants, 40 elected and 40 declined ECS. Trends regarding reasons for electing or declining ECS include ethnicity, desire for genetic risk information, lack of family history, perceived likelihood of being a carrier, and perceived impact on reproductive decisions. Individuals who declined ECS seemed to prefer ethnicity-based carrier screening and believed that ECS would increase their anxiety, whereas individuals who elected ECS seemed to prefer more screening and tended to believe that ECS would reduce their anxiety. These findings provide insight on decision-making with regard to ECS and can help guide interactions that genetic counselors and other healthcare providers have with patients, including assisting patients in the decision-making process.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat American College of Obstetricians and Gynecologists (ACOG). (2011). Committee opinion number 486: update on carrier screening for cystic fibrosis. Obstetrics & Gynecology, 117(4), 1028–1031.CrossRef American College of Obstetricians and Gynecologists (ACOG). (2011). Committee opinion number 486: update on carrier screening for cystic fibrosis. Obstetrics & Gynecology, 117(4), 1028–1031.CrossRef
Zurück zum Zitat American College of Obstetricians and Gynecologists (ACOG). (2017a). Committee opinion number 690: carrier screening in the age of genomic medicine. Obstetrics & Gynecology, 129, e35–e40.CrossRef American College of Obstetricians and Gynecologists (ACOG). (2017a). Committee opinion number 690: carrier screening in the age of genomic medicine. Obstetrics & Gynecology, 129, e35–e40.CrossRef
Zurück zum Zitat American College of Obstetricians and Gynecologists (ACOG). (2017b). Committee opinion number 691: carrier screening for genetic conditions. Obstetrics & Gynecology, 129, e41–e55.CrossRef American College of Obstetricians and Gynecologists (ACOG). (2017b). Committee opinion number 691: carrier screening for genetic conditions. Obstetrics & Gynecology, 129, e41–e55.CrossRef
Zurück zum Zitat Chen, L., & Goodson, P. (2007). Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic review. Genetics in Medicine, 9(7), 442–450.CrossRefPubMed Chen, L., & Goodson, P. (2007). Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic review. Genetics in Medicine, 9(7), 442–450.CrossRefPubMed
Zurück zum Zitat Cho, D., McGowan, M. L., Metcalfe, J., & Sharp, R. R. (2013). Expanded carrier screening in reproductive healthcare: perspectives from genetics professionals. Human Reproduction, 28(6), 1725–1730.CrossRefPubMed Cho, D., McGowan, M. L., Metcalfe, J., & Sharp, R. R. (2013). Expanded carrier screening in reproductive healthcare: perspectives from genetics professionals. Human Reproduction, 28(6), 1725–1730.CrossRefPubMed
Zurück zum Zitat Edwards, J. G., Feldman, G., Goldberg, J., Gregg, A. R., Norton, M. E., Rose, N. C., et al. (2015). Expanded carrier screening in reproductive medicine—points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstetrics & Gynecology, 125(3), 653–662.CrossRef Edwards, J. G., Feldman, G., Goldberg, J., Gregg, A. R., Norton, M. E., Rose, N. C., et al. (2015). Expanded carrier screening in reproductive medicine—points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstetrics & Gynecology, 125(3), 653–662.CrossRef
Zurück zum Zitat Ekstrand Ragnar, M., Tyden, T., Kihlbom, U., & Larsson, M. (2016). Swedish parents’ interest in preconception genetic carrier screening. Upsala Journal of Medical Sciences, 121(4), 289–294.CrossRefPubMedCentral Ekstrand Ragnar, M., Tyden, T., Kihlbom, U., & Larsson, M. (2016). Swedish parents’ interest in preconception genetic carrier screening. Upsala Journal of Medical Sciences, 121(4), 289–294.CrossRefPubMedCentral
Zurück zum Zitat Gilmore, M. J., Schneider, J., Davis, J. V., Kauffman, T. L., Leo, M. C., Bergen, K., et al. (2017). Reasons for declining preconception expanded carrier screening using genome sequencing. Journal of Genetic Counseling, 26(5), 971–979.CrossRefPubMedPubMedCentral Gilmore, M. J., Schneider, J., Davis, J. V., Kauffman, T. L., Leo, M. C., Bergen, K., et al. (2017). Reasons for declining preconception expanded carrier screening using genome sequencing. Journal of Genetic Counseling, 26(5), 971–979.CrossRefPubMedPubMedCentral
Zurück zum Zitat Grody, W. W. (2016). Where to draw the boundaries for prenatal carrier screening. Journal of the American Medical Association, 316(7), 717–719.CrossRefPubMed Grody, W. W. (2016). Where to draw the boundaries for prenatal carrier screening. Journal of the American Medical Association, 316(7), 717–719.CrossRefPubMed
Zurück zum Zitat Grody, W. W., Cutting, G. R., Klinger, K. W., Richards, C. S., Watson, M. S., & Desnick, R. J. (2001). Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genetics in Medicine, 3(2), 149–154.CrossRefPubMed Grody, W. W., Cutting, G. R., Klinger, K. W., Richards, C. S., Watson, M. S., & Desnick, R. J. (2001). Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genetics in Medicine, 3(2), 149–154.CrossRefPubMed
Zurück zum Zitat Grody, W. W., Thompson, B. H., Gregg, A. R., Bean, L. H., Monaghan, K. G., Schneider, A., & Lebo, R. V. (2013). ACMG position statement on prenatal/preconception expanded carrier screening. Obstetrical & Gynecological Survey, 68(12), 785–787.CrossRef Grody, W. W., Thompson, B. H., Gregg, A. R., Bean, L. H., Monaghan, K. G., Schneider, A., & Lebo, R. V. (2013). ACMG position statement on prenatal/preconception expanded carrier screening. Obstetrical & Gynecological Survey, 68(12), 785–787.CrossRef
Zurück zum Zitat Haque, I. S., Lazarin, G. A., Kang, H. P., Evans, E. A., Goldberg, J. D., & Wapner, R. J. (2016). Modeled fetal risk of genetic diseases identified by expanded carrier screening. Journal of the American Medical Association, 316(7), 734–742.CrossRefPubMed Haque, I. S., Lazarin, G. A., Kang, H. P., Evans, E. A., Goldberg, J. D., & Wapner, R. J. (2016). Modeled fetal risk of genetic diseases identified by expanded carrier screening. Journal of the American Medical Association, 316(7), 734–742.CrossRefPubMed
Zurück zum Zitat Harris, H., Scotcher, D., Hartley, N., Wallace, A., Craufurd, D., & Harris, R. (1996). Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice. British Journal of General Practice, 46, 225–227.PubMed Harris, H., Scotcher, D., Hartley, N., Wallace, A., Craufurd, D., & Harris, R. (1996). Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice. British Journal of General Practice, 46, 225–227.PubMed
Zurück zum Zitat Holtkamp, K. C. A., van Maarle, M. C., Schouten, M. J. E., Dondorp, W. J., Lakerman, P., & Henneman, L. (2016). Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening? European Journal of Human Genetics, 24, 171–177.CrossRefPubMed Holtkamp, K. C. A., van Maarle, M. C., Schouten, M. J. E., Dondorp, W. J., Lakerman, P., & Henneman, L. (2016). Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening? European Journal of Human Genetics, 24, 171–177.CrossRefPubMed
Zurück zum Zitat Ioannou, L., McClaren, B., Massie, J., Lewis, S., Metcalfe, S. A., Forrest, L., & Deltaycki, M. B. (2014). Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research. Genetics in Medicine, 16(3), 207–216.CrossRefPubMed Ioannou, L., McClaren, B., Massie, J., Lewis, S., Metcalfe, S. A., Forrest, L., & Deltaycki, M. B. (2014). Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research. Genetics in Medicine, 16(3), 207–216.CrossRefPubMed
Zurück zum Zitat Julian, L. J. (2011). Measures of anxiety: state-trait anxiety inventory (STAI), beck anxiety inventory (BAI), and hospital anxiety and depression scale-anxiety (HADS-A). Arthritis Care & Research, 63, S467–S472.CrossRef Julian, L. J. (2011). Measures of anxiety: state-trait anxiety inventory (STAI), beck anxiety inventory (BAI), and hospital anxiety and depression scale-anxiety (HADS-A). Arthritis Care & Research, 63, S467–S472.CrossRef
Zurück zum Zitat Kauffman, T. L., Irving, S. A., Leo, M. C., Gilmore, M. J., Himes, P., McMullen, C. K., et al. (2017). The NextGen study: patient motivation for participation in genomic sequencing for carrier status. Molecular Genetics & Genomic Medicine, 5(5), 508–515.CrossRef Kauffman, T. L., Irving, S. A., Leo, M. C., Gilmore, M. J., Himes, P., McMullen, C. K., et al. (2017). The NextGen study: patient motivation for participation in genomic sequencing for carrier status. Molecular Genetics & Genomic Medicine, 5(5), 508–515.CrossRef
Zurück zum Zitat Kingsmore, S. (2012). Comprehensive carrier screening and molecular diagnostic testing for recessive childhood disease. PLoS Currents, 4, e4f9877ab8ffa9.CrossRefPubMedCentral Kingsmore, S. (2012). Comprehensive carrier screening and molecular diagnostic testing for recessive childhood disease. PLoS Currents, 4, e4f9877ab8ffa9.CrossRefPubMedCentral
Zurück zum Zitat Langlois, S., Benn, P., & Wilkins-Haug, L. (2015). Current controversies in prenatal diagnosis 4: preconception expanded carrier screening should replace all current prenatal screening for specific single gene disorders. Prenatal Diagnosis, 35, 23–28.CrossRefPubMed Langlois, S., Benn, P., & Wilkins-Haug, L. (2015). Current controversies in prenatal diagnosis 4: preconception expanded carrier screening should replace all current prenatal screening for specific single gene disorders. Prenatal Diagnosis, 35, 23–28.CrossRefPubMed
Zurück zum Zitat Lazarin, G. A., Detweiler, S., Nazareth, S. B., & Ashkinadze, E. (2015). Genetic counselors’ perspectives and practices regarding expanded carrier screening after initial clinical availability. Journal of Genetic Counseling, 25(2), 395–404.CrossRefPubMedPubMedCentral Lazarin, G. A., Detweiler, S., Nazareth, S. B., & Ashkinadze, E. (2015). Genetic counselors’ perspectives and practices regarding expanded carrier screening after initial clinical availability. Journal of Genetic Counseling, 25(2), 395–404.CrossRefPubMedPubMedCentral
Zurück zum Zitat Liu, X., Law, H. Y., Tan, Y. M., & Hong, Y. (2010). High-throughput B-thalassemia carrier screening by allele-specific Q-primer real-time polymerase chain reaction. Analytical Biochemistry, 404(1), 97–99.CrossRefPubMed Liu, X., Law, H. Y., Tan, Y. M., & Hong, Y. (2010). High-throughput B-thalassemia carrier screening by allele-specific Q-primer real-time polymerase chain reaction. Analytical Biochemistry, 404(1), 97–99.CrossRefPubMed
Zurück zum Zitat Plantinga, M., Birnie, E., Abbott, K., Sinke, R. J., Lucassen, A. M., Schuurmans, J., et al. (2016). Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases. European Journal of Human Genetics, 24, 1417–1423.CrossRefPubMedPubMedCentral Plantinga, M., Birnie, E., Abbott, K., Sinke, R. J., Lucassen, A. M., Schuurmans, J., et al. (2016). Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases. European Journal of Human Genetics, 24, 1417–1423.CrossRefPubMedPubMedCentral
Zurück zum Zitat Pletcher, B. A., Gross, S. J., Monaghan, K. G., Driscoll, D. A., & Watson, M. S. (2008). The future is now: carrier screening for all populations. Genetics in Medicine, 10(1), 33–36.CrossRefPubMed Pletcher, B. A., Gross, S. J., Monaghan, K. G., Driscoll, D. A., & Watson, M. S. (2008). The future is now: carrier screening for all populations. Genetics in Medicine, 10(1), 33–36.CrossRefPubMed
Zurück zum Zitat Poppelaars, F. A., Henneman, L., Ader, H. J., Cornel, M. C., Hermens, R. P., van der Wal, G., & ten Kate, L. P. (2004). Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target population. Genetic Testing, 8, 80–89.CrossRefPubMed Poppelaars, F. A., Henneman, L., Ader, H. J., Cornel, M. C., Hermens, R. P., van der Wal, G., & ten Kate, L. P. (2004). Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target population. Genetic Testing, 8, 80–89.CrossRefPubMed
Zurück zum Zitat Rothwell, E., Johnson, E., Mathiesen, A., Golden, K., Metcalf, A., Rose, N. C., & Botkin, J. R. (2017). Experiences among women with positive prenatal expanded carrier screening results. Journal of Genetic Counseling, 26(4), 690–696.CrossRefPubMed Rothwell, E., Johnson, E., Mathiesen, A., Golden, K., Metcalf, A., Rose, N. C., & Botkin, J. R. (2017). Experiences among women with positive prenatal expanded carrier screening results. Journal of Genetic Counseling, 26(4), 690–696.CrossRefPubMed
Zurück zum Zitat Schneider, J. L., Goddard, K. A., Davis, J., Wilfond, B., Kauffman, T. L., Reiss, J. A., et al. (2016). “Is it worth knowing?” Focus group participants’ perceived utility of genomic preconception carrier screening. Journal of Genetic Counseling, 25, 135–145.CrossRefPubMed Schneider, J. L., Goddard, K. A., Davis, J., Wilfond, B., Kauffman, T. L., Reiss, J. A., et al. (2016). “Is it worth knowing?” Focus group participants’ perceived utility of genomic preconception carrier screening. Journal of Genetic Counseling, 25, 135–145.CrossRefPubMed
Zurück zum Zitat Uhlmann, W. R., Schuette, J. L., & Yashar, B. M. (2009). A guide to genetic counseling (2nd ed.). New York: Wiley-Blackwell. Uhlmann, W. R., Schuette, J. L., & Yashar, B. M. (2009). A guide to genetic counseling (2nd ed.). New York: Wiley-Blackwell.
Zurück zum Zitat Veach, P. M., LeRoy, B. S., & Bartels, D. M. (2003). Facilitating the genetic counseling process: a practice manual. New York: Springer-Verlag New York, Inc.. Veach, P. M., LeRoy, B. S., & Bartels, D. M. (2003). Facilitating the genetic counseling process: a practice manual. New York: Springer-Verlag New York, Inc..
Metadaten
Titel
Pregnant Women’s Perspectives on Expanded Carrier Screening
verfasst von
Lauren Propst
Gwendolyn Connor
Megan Hinton
Tabitha Poorvu
Jeffrey Dungan
Publikationsdatum
23.02.2018
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 5/2018
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-018-0232-x

Weitere Artikel der Ausgabe 5/2018

Journal of Genetic Counseling 5/2018 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.